_id
69147e27ccc777a4e85d91dc
Ticker
MYNDF
Name
MYND Lifesciencs Inc
Exchange
PINK
Address
Unit 150, Port Coquitlam, BC, Canada, V3C 2B2
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.myndsciences.com
Description
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
Last Close
0.0081
Volume
-
Current Price
0.0081
Change
0
Last Updated
2026-01-05T11:08:13.856Z
Image
-
Ipo Date
-
Market Cap
894811
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-07-31
Revenue
0
Cost Of Revenue
60000
Gross Profit
-60000
Operating Expenses
281774
Operating Income
-341774
Interest Expense
37500
Pretax Income
-379274
Net Income
-379274
Eps
-0.008196155197284801
Dividends Per Share
-
Shares Outstanding
47817182
Income Tax Expense
-
EBITDA
-341692
Operating Margin
-
Total Other Income Expense Net
-37500
Cash
497
Short Term Investments
-
Receivables
605838
Inventories
-
Total Current Assets
614631
Property Plant Equipment
5087
Total Assets
719718
Payables
1239061
Short Term Debt
3000000
Long Term Debt
-
Total Liabilities
6708481
Equity
-5988763
Bs_currency_symbol
CAD
Depreciation
82
Change In Working Capital
340439
Cash From Operations
-1253
Capital Expenditures
1306
Cash From Investing
-57
Cash From Financing
0
Net Change In Cash
-1310
Cf_currency_symbol
CAD
PE
-
PB
-0.06258795921628556
ROE
6.333094163185285
ROA
-52.697584331641
FCF
-2559
Fcf Percent
-
Piotroski FScore
1
Health Score
28
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2024-07-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
60000
Quarters > 0 > income Statement > gross Profit
-60000
Quarters > 0 > income Statement > operating Expenses
281774
Quarters > 0 > income Statement > operating Income
-341774
Quarters > 0 > income Statement > interest Expense
37500
Quarters > 0 > income Statement > pretax Income
-379274
Quarters > 0 > income Statement > net Income
-379274
Quarters > 0 > income Statement > eps
-0.008196155197284801
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
46274624
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-341692
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-37500
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
497
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
605838
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
614631
Quarters > 0 > balance Sheet > property Plant Equipment
5087
Quarters > 0 > balance Sheet > total Assets
719718
Quarters > 0 > balance Sheet > payables
1239061
Quarters > 0 > balance Sheet > short Term Debt
3000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6708481
Quarters > 0 > balance Sheet > equity
-5988763
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-379274
Quarters > 0 > cash Flow > depreciation
82
Quarters > 0 > cash Flow > change In Working Capital
340439
Quarters > 0 > cash Flow > cash From Operations
-1253
Quarters > 0 > cash Flow > capital Expenditures
1306
Quarters > 0 > cash Flow > cash From Investing
-57
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-1310
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.008196155197284801
Quarters > 0 > ratios > PB
-0.06258795921628556
Quarters > 0 > ratios > ROE
6.333094163185285
Quarters > 0 > ratios > ROA
-52.697584331641
Quarters > 0 > ratios > FCF
-2559
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2024-04-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
89139
Quarters > 1 > income Statement > gross Profit
-89139
Quarters > 1 > income Statement > operating Expenses
132091
Quarters > 1 > income Statement > operating Income
-221230
Quarters > 1 > income Statement > interest Expense
38334
Quarters > 1 > income Statement > pretax Income
-259564
Quarters > 1 > income Statement > net Income
-259564
Quarters > 1 > income Statement > eps
-0.005609208191513344
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
46274624
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-220578
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-38334
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
1807
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
689740
Quarters > 1 > balance Sheet > inventories
1
Quarters > 1 > balance Sheet > total Current Assets
702777
Quarters > 1 > balance Sheet > property Plant Equipment
5169
Quarters > 1 > balance Sheet > total Assets
707946
Quarters > 1 > balance Sheet > payables
1156602
Quarters > 1 > balance Sheet > short Term Debt
3000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6317435
Quarters > 1 > balance Sheet > equity
-5609489
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-259564
Quarters > 1 > cash Flow > depreciation
652
Quarters > 1 > cash Flow > change In Working Capital
-112063
Quarters > 1 > cash Flow > cash From Operations
39818
Quarters > 1 > cash Flow > capital Expenditures
1306
Quarters > 1 > cash Flow > cash From Investing
57
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
39875
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.005609208191513344
Quarters > 1 > ratios > PB
-0.06681971466563175
Quarters > 1 > ratios > ROE
4.627230751321555
Quarters > 1 > ratios > ROA
-36.66437835654131
Quarters > 1 > ratios > FCF
38512
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2024-01-31
Quarters > 2 > income Statement > revenue
1
Quarters > 2 > income Statement > cost Of Revenue
60000
Quarters > 2 > income Statement > gross Profit
-59999
Quarters > 2 > income Statement > operating Expenses
274432
Quarters > 2 > income Statement > operating Income
-334431
Quarters > 2 > income Statement > interest Expense
38333
Quarters > 2 > income Statement > pretax Income
-372764
Quarters > 2 > income Statement > net Income
-372764
Quarters > 2 > income Statement > eps
-0.007923171987759813
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
47047319
Quarters > 2 > income Statement > income Tax Expense
-42622
Quarters > 2 > income Statement > EBITDA
-333777
Quarters > 2 > income Statement > operating Margin
-33443100
Quarters > 2 > income Statement > total Other Income Expense Net
-38332
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
265
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
762664
Quarters > 2 > balance Sheet > inventories
1829
Quarters > 2 > balance Sheet > total Current Assets
765524
Quarters > 2 > balance Sheet > property Plant Equipment
5822
Quarters > 2 > balance Sheet > total Assets
771346
Quarters > 2 > balance Sheet > payables
1250440
Quarters > 2 > balance Sheet > short Term Debt
3000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6121271
Quarters > 2 > balance Sheet > equity
-5349925
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-372764
Quarters > 2 > cash Flow > depreciation
654
Quarters > 2 > cash Flow > change In Working Capital
333786
Quarters > 2 > cash Flow > cash From Operations
-38324
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-38324
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.007923171987759813
Quarters > 2 > ratios > PB
-0.07123151892783544
Quarters > 2 > ratios > ROE
6.967649079192699
Quarters > 2 > ratios > ROA
-48.32643197734869
Quarters > 2 > ratios > FCF
-38324
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-38324
Quarters > 2 > health Score
21
Quarters > 3 > quarter
2023-10-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
60000
Quarters > 3 > income Statement > gross Profit
-60000
Quarters > 3 > income Statement > operating Expenses
313579
Quarters > 3 > income Statement > operating Income
-388544
Quarters > 3 > income Statement > interest Expense
124261
Quarters > 3 > income Statement > pretax Income
469037
Quarters > 3 > income Statement > net Income
469037
Quarters > 3 > income Statement > eps
0.00978505862227229
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
47934000
Quarters > 3 > income Statement > income Tax Expense
124262
Quarters > 3 > income Statement > EBITDA
-387652
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
857582
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
257
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
777916
Quarters > 3 > balance Sheet > inventories
12104
Quarters > 3 > balance Sheet > total Current Assets
791068
Quarters > 3 > balance Sheet > property Plant Equipment
6475
Quarters > 3 > balance Sheet > total Assets
797543
Quarters > 3 > balance Sheet > payables
1095011
Quarters > 3 > balance Sheet > short Term Debt
3000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5774704
Quarters > 3 > balance Sheet > equity
-4977161
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
469037
Quarters > 3 > cash Flow > depreciation
892
Quarters > 3 > cash Flow > change In Working Capital
397664
Quarters > 3 > cash Flow > cash From Operations
-173016
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
223101
Quarters > 3 > cash Flow > cash From Financing
-50
Quarters > 3 > cash Flow > net Change In Cash
85
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.00978505862227229
Quarters > 3 > ratios > PB
-0.07800941138934425
Quarters > 3 > ratios > ROE
-9.423785969551718
Quarters > 3 > ratios > ROA
58.810245967929
Quarters > 3 > ratios > FCF
-173016
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
47
Annuals > 0 > quarter
2023-10-31
Annuals > 0 > income Statement > revenue
92990
Annuals > 0 > income Statement > cost Of Revenue
332990
Annuals > 0 > income Statement > gross Profit
-240000
Annuals > 0 > income Statement > operating Expenses
1588763
Annuals > 0 > income Statement > operating Income
-1828763
Annuals > 0 > income Statement > interest Expense
731755
Annuals > 0 > income Statement > pretax Income
-1517860
Annuals > 0 > income Statement > net Income
-1517860
Annuals > 0 > income Statement > eps
-0.03211094776080266
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
47269237
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1825196
Annuals > 0 > income Statement > operating Margin
-1966.6232928271857
Annuals > 0 > income Statement > total Other Income Expense Net
310903
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
257
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
777916
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
791068
Annuals > 0 > balance Sheet > property Plant Equipment
6475
Annuals > 0 > balance Sheet > total Assets
797543
Annuals > 0 > balance Sheet > payables
1095011
Annuals > 0 > balance Sheet > short Term Debt
3000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5774704
Annuals > 0 > balance Sheet > equity
-4977161
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1517860
Annuals > 0 > cash Flow > depreciation
20986
Annuals > 0 > cash Flow > change In Working Capital
1749187
Annuals > 0 > cash Flow > cash From Operations
-198256
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
198101
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-155
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.03211094776080266
Annuals > 0 > ratios > PB
-0.0769275536194228
Annuals > 0 > ratios > ROE
30.49650192147692
Annuals > 0 > ratios > ROA
-190.31701112040352
Annuals > 0 > ratios > FCF
-198256
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-2.1320141950747393
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2022-10-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
180000
Annuals > 1 > income Statement > gross Profit
-180000
Annuals > 1 > income Statement > operating Expenses
2883292
Annuals > 1 > income Statement > operating Income
-3003466
Annuals > 1 > income Statement > interest Expense
662905
Annuals > 1 > income Statement > pretax Income
-3697268
Annuals > 1 > income Statement > net Income
-3567322
Annuals > 1 > income Statement > eps
-0.07642441763187613
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
46677778
Annuals > 1 > income Statement > income Tax Expense
-129946
Annuals > 1 > income Statement > EBITDA
-3058596
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-693802
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
412
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
128411
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
238823
Annuals > 1 > balance Sheet > property Plant Equipment
115296
Annuals > 1 > balance Sheet > total Assets
654119
Annuals > 1 > balance Sheet > payables
710667
Annuals > 1 > balance Sheet > short Term Debt
2526745
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4186298
Annuals > 1 > balance Sheet > equity
-3532179
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-3567322
Annuals > 1 > cash Flow > depreciation
59826
Annuals > 1 > cash Flow > change In Working Capital
1218594
Annuals > 1 > cash Flow > cash From Operations
-1819455
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-80000
Annuals > 1 > cash Flow > cash From Financing
0
Annuals > 1 > cash Flow > net Change In Cash
-1899455
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.07642441763187613
Annuals > 1 > ratios > PB
-0.10704157456346351
Annuals > 1 > ratios > ROE
100.99493825199686
Annuals > 1 > ratios > ROA
-545.3628468214499
Annuals > 1 > ratios > FCF
-1819455
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2021-10-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
4291579
Annuals > 2 > income Statement > operating Income
-4291579
Annuals > 2 > income Statement > interest Expense
134882
Annuals > 2 > income Statement > pretax Income
-4535506
Annuals > 2 > income Statement > net Income
-4367198
Annuals > 2 > income Statement > eps
-0.09714128625113627
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
44957177
Annuals > 2 > income Statement > income Tax Expense
-168308
Annuals > 2 > income Statement > EBITDA
-4280576
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-243927
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
1899867
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
97664
Annuals > 2 > balance Sheet > inventories
44499
Annuals > 2 > balance Sheet > total Current Assets
2042075
Annuals > 2 > balance Sheet > property Plant Equipment
328334
Annuals > 2 > balance Sheet > total Assets
2670419
Annuals > 2 > balance Sheet > payables
212077
Annuals > 2 > balance Sheet > short Term Debt
69589
Annuals > 2 > balance Sheet > long Term Debt
2002296
Annuals > 2 > balance Sheet > total Liabilities
2738387
Annuals > 2 > balance Sheet > equity
-67968
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-4367198
Annuals > 2 > cash Flow > depreciation
86118
Annuals > 2 > cash Flow > change In Working Capital
-213029
Annuals > 2 > cash Flow > cash From Operations
-2982313
Annuals > 2 > cash Flow > capital Expenditures
149394
Annuals > 2 > cash Flow > cash From Investing
2130410
Annuals > 2 > cash Flow > cash From Financing
2751770
Annuals > 2 > cash Flow > net Change In Cash
1899867
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.09714128625113627
Annuals > 2 > ratios > PB
-5.357714420021186
Annuals > 2 > ratios > ROE
6425.37370527307
Annuals > 2 > ratios > ROA
-163.53980405322162
Annuals > 2 > ratios > FCF
-3131707
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2020-10-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
56466
Annuals > 3 > income Statement > operating Income
-56466
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-56466
Annuals > 3 > income Statement > net Income
-56466
Annuals > 3 > income Statement > eps
-0.0020004119432946665
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28227186
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
70
Annuals > 3 > balance Sheet > payables
2521
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
53688
Annuals > 3 > balance Sheet > equity
-53618
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-56466
Annuals > 3 > cash Flow > depreciation
86118
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-2778
Annuals > 3 > cash Flow > capital Expenditures
43900
Annuals > 3 > cash Flow > cash From Investing
2130410
Annuals > 3 > cash Flow > cash From Financing
2778
Annuals > 3 > cash Flow > net Change In Cash
1899867
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.0020004119432946665
Annuals > 3 > ratios > PB
-4.264243474206423
Annuals > 3 > ratios > ROE
105.31164907307246
Annuals > 3 > ratios > ROA
-80665.71428571429
Annuals > 3 > ratios > FCF
-46678
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
38
Valuation > metrics > PE
-0.008196155197284801
Valuation > metrics > PB
-0.06258795921628556
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
6.333094163185285
Profitability > metrics > ROA
-61.7075936618882
Profitability > final Score
28
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-9.113973333333334
Risk > final Score
-6
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.14499225182180675
Liquidity > metrics > Quick Ratio
0.14499225182180675
Liquidity > final Score
17
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
24
Prev Profitabilities > 1
14
Prev Profitabilities > 2
45
Prev Risks > 0
7
Prev Risks > 1
-5
Prev Risks > 2
17
Prev Liquidities > 0
18
Prev Liquidities > 1
19
Prev Liquidities > 2
20
Updated At
2026-01-20T22:15:28.956Z
Earnings History > 0 > period
2024-07-31
Earnings History > 0 > report Date
2024-07-31
Earnings History > 0 > date
2024-07-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.006
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-04-30
Earnings History > 1 > report Date
2024-04-30
Earnings History > 1 > date
2024-04-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0041
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-01-31
Earnings History > 2 > report Date
2024-01-31
Earnings History > 2 > date
2024-01-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0059
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-10-31
Earnings History > 3 > report Date
2023-10-31
Earnings History > 3 > date
2023-10-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.0072
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-07-31
Earnings History > 4 > report Date
2023-07-31
Earnings History > 4 > date
2023-07-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0085
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-04-30
Earnings History > 5 > report Date
2023-04-30
Earnings History > 5 > date
2023-04-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0099
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-01-31
Earnings History > 6 > report Date
2023-01-31
Earnings History > 6 > date
2023-01-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0135
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-10-31
Earnings History > 7 > report Date
2022-10-31
Earnings History > 7 > date
2022-10-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0089
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-07-31
Earnings History > 8 > report Date
2022-07-31
Earnings History > 8 > date
2022-07-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0143
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-04-30
Earnings History > 9 > report Date
2022-04-30
Earnings History > 9 > date
2022-04-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0147
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-01-31
Earnings History > 10 > report Date
2022-01-31
Earnings History > 10 > date
2022-01-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0225
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-06-30
Earnings History > 11 > report Date
2021-07-31
Earnings History > 11 > date
2021-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0152
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0152
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-04-30
Earnings History > 12 > report Date
2021-07-31
Earnings History > 12 > date
2021-04-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0152
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0152
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-03-31
Earnings History > 13 > report Date
2021-04-30
Earnings History > 13 > date
2021-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0138
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0138
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-01-31
Earnings History > 14 > report Date
2021-04-30
Earnings History > 14 > date
2021-01-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0138
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0138
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2020-12-31
Earnings History > 15 > report Date
2021-01-31
Earnings History > 15 > date
2020-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0216
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0216
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2020-10-31
Earnings History > 16 > report Date
2021-01-31
Earnings History > 16 > date
2020-10-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0216
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0216
Earnings History > 16 > surprise Percent
-
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-07-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of MYND Lifesciencs Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-07-31
EPS Actual
-0.006
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-07-31)
(Last Updated 2024-07-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-07-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-07-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.